The largest database of trusted experimental protocols

13 protocols using nbqx disodium salt

1

Clozapine-N-Oxide Pharmacological Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clozapine-N-Oxide was generously provided by the NIMH Chemical Synthesis and Drug Supply Program (NIMH C-929). CNO was made fresh each day and dissolved in DMSO (0.5% final concentration) and diluted to 0.1 mg/mL in 0.9% saline USP. Tetrodotoxin (TTX), DL-AP5, and NBQX disodium salt were purchased from Tocris Biosciences (Ellisville, MO).
+ Open protocol
+ Expand
2

Drug Preparation for Seizure Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
For seizure susceptibility testing, flurothyl (Bis(2,2,2-trifluoroethyl ether) and pentylenetetrazole (PTZ) were obtained from Sigma-Aldrich, and kainate was obtained from Tocris. All drugs were prepared immediately prior to test injections at their final concentrations and shielded from light. For use in acute slice electrophysiology experiments, R-CPP and NBQX disodium salt were obtained from Tocris Bioscience. Na3GTP and TTX were from Roche and Alomone Laboratories, respectively. Drugs were dissolved as stock solutions in either water or DMSO and aliquoted and frozen at −30 °C before use. Each drug was diluted to the appropriate concentrations by adding to the perfusate immediately before the experiment. The final concentration of DMSO in the perfusate was 0.1%.
+ Open protocol
+ Expand
3

Pharmacological Agents in Neurophysiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dyes and drugs were purchased from the following suppliers: (RS)-AMPA hydrobromide (AMPA), Kainate (KA), GYKI 52466 hydrochloride (GYKI), DL-threo-β-Benzyloxyaspartic acid (TBOA), NBQX disodium salt (NBQX), DL-AP5 sodium salt (APV), dynamin inhibitory peptide (QVPSRPNRAP), dynamin inhibitory peptide myristoylated (scrambled), dynamin inhibitory peptide myristoylated, cyclothiazide, mecamylamine, dhβe, and Dynasore (Tocris, Ellisville, MO, USA); N-Methyl-D-Aspartate (NMDA), tetrodotoxyn (TTX), Strychnine, Bicuculline and L-glutamate, atropine (Sigma, St Louis, MO); Fluoro-Gold (Fluorochrome, Inc., Denver, CO, USA); Lucifer Yellow (LY), Acridine Orange 10-Nonyl (AO), 6-methoxy-N-ethylquinolinium iodide (MEQ), and Florescien-5-isothiocyan (FITC) were from Invitrogen. Dynasore was dissolved in DMSO. When bath applied to the cord, the concentration of DMSO was less than 0.1%. All other drugs were dissolved in artificial cerebrospinal fluid (aCSF).
+ Open protocol
+ Expand
4

Purchasing Pharmacological Agents for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
NBQX disodium salt and SR95531 (gabazine) were purchased from Tocris Biosciences. All the remaining drugs (tamoxifen and compounds to prepare ACSF and intracellular solutions) were purchased from Sigma.
+ Open protocol
+ Expand
5

Isolating Perisomatic Inhibitory Inputs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CA1 pyramidal neurons were visualized with infrared differential interference contrast microscopy to perform whole-cell voltage-clamp recordings. Neighbouring uninfected and Cre-mCherry-infected neurons were identified using epifluorescence driven by a light-emitting diode. Neurons were held at −70 mV for all experiments. Recording pipettes made from borosilicate glass (open resistance between 2 and 4 MΩ) were filled with an internal solution containing (in mM): 147 CsCl, 5 Na2-phosphocreatine, 10 HEPES, 2 MgATP, 0.3 Na2GTP, 2 EGTA and 5 QX-314 (Sigma-Aldrich). Internal solution was prepared in a single batch, with osmolarity adjusted to 290 mOsm with double-distilled water and pH adjusted to 7.3 with CsOH, and was stored at −20 °C. To record IPSCs, inhibitory currents were pharmacologically isolated through bath application of 10 µM (R)-CPP (Tocris Bioscience) and 10 µM NBQX disodium salt (Tocris Bioscience). Extracellular stimulation of perisomatic inhibitory axons was achieved using a concentric bipolar electrode (FHC) placed within the centre of the stratum pyramidale and within 100–200 μm laterally of the pair of voltage-clamped cells. The stimulus strength used was the minimum stimulation required to generate a reliable IPSC in both neurons.
+ Open protocol
+ Expand
6

Neuroscience Research Reagents Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
DL-TBOA, DL-AP-5 sodium salt, MK-801 maleate, ketamine hydrochloride, NBQX disodium salt, were purchased from Tocris Bioscience (Bristol, UK).
+ Open protocol
+ Expand
7

Dose-Dependent Pharmacological Interventions

Check if the same lab product or an alternative is used in the 5 most similar protocols
NBQX disodium salt (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt) (Tocris Bioscience) was dissolved in 0.9% saline and administered intraperitoneally (i.p.) at doses of 0.0 (vehicle control), 1.0, 2.0, 4.0, 6.0, and 8.0 mg/kg. THIP hydrochloride (4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridine-3-ol hydrochloride) (Tocris Bioscience) was dissolved in 0.9% saline, and administered i.p. at doses of 0.0 (vehicle control), 1.0, 2.0 and 4.0 mg/kg. The non-competitive NMDA receptor antagonist ifenprodil hemitartrate ((1R*,2S*)-erythro-2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)-1-propanol hemi-(DL)-tartrate) (Tocris Bioscience) was dissolved in double-distilled sterile water (ddH2O) and administered i.p. at doses of 0 (vehicle control), 1.5, 3.0 and 6.0 mg/kg. All doses were administered at a volume of 2 ml of drug solution/kg body weight.
+ Open protocol
+ Expand
8

Pharmacological Characterization of Ketamine

Check if the same lab product or an alternative is used in the 5 most similar protocols
(S)-(+)-Ketamine hydrochloride (Tocris Cookson, Ltd., Bristol, UK), (R)-ketamine hydrochloride (Cayman Chemicals, Ann Arbor, USA), LY341495 disodium salt (Tocris Cookson, Ltd.), NBQX disodium salt (Tocris Cookson Ltd.), LY379268 disodium salt (Tocris Cookson, Ltd.) and ketamine hydrochloride solution (Bioketan, Biowet, Puławy, Poland) were diluted with 0.9% NaCl. ANA-12 (Tocris Cookson Ltd.) was dissolved in 2% DMSO. Herein, 0.9% NaCl or 2% DMSO was used as a vehicle. All compounds and vehicles were injected intraperitoneally (i.p.) at a constant volume of 10 mL/kg.
+ Open protocol
+ Expand
9

Drug Preparation for Seizure Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
For seizure susceptibility testing, flurothyl (Bis(2,2,2-trifluoroethyl ether) and pentylenetetrazole (PTZ) were obtained from Sigma-Aldrich, and kainate was obtained from Tocris. All drugs were prepared immediately prior to test injections at their final concentrations and shielded from light. For use in acute slice electrophysiology experiments, R-CPP and NBQX disodium salt were obtained from Tocris Bioscience. Na3GTP and TTX were from Roche and Alomone Laboratories, respectively. Drugs were dissolved as stock solutions in either water or DMSO and aliquoted and frozen at −30 °C before use. Each drug was diluted to the appropriate concentrations by adding to the perfusate immediately before the experiment. The final concentration of DMSO in the perfusate was 0.1%.
+ Open protocol
+ Expand
10

Dose-Dependent Effects of AMPA and GABAA Receptor Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
The design for Experiment 1 was a 2 age (adolescent; adult) × 2 sex (male; female) × 6 dose (0.0, 1.0, 2.0, 4.0, 6.0, 8.0 mg/kg NBQX) factorial with 10 animals per group (N = 240). The test doses of the selective AMPA receptor antagonist, NBQX disodium salt (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt; Tocris Bioscience; half-life approximately 30 min [7 (link),27 (link)] were dissolved in 0.9% sterile saline and delivered intraperitoneally (i.p.) at a volume of 2 ml/kg body weight, with control animals receiving an equivalent volume of saline. The design for Experiment 2 was a 2 age (adolescent; adult) × 2 sex (male; female) × 4 dose (0.0, 1.0, 2.0, 4.0 mg/kg THIP) factorial with 8–10 animals per group (N = 217). The extrasynaptic GABAA receptor agonist THIP hydrochloride (4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridine-3-ol hydrochloride); Tocris Bioscience; half-life approximately 1.5–2 h [2 ] was also delivered i.p. in 0.9% sterile saline vehicle at doses of 0.0 (saline) 1.0, 2.0 and 4.0 mg/kg in a volume of 2 ml/kg body weight. In both experiments, same sex littermates were assigned semi-randomly to different drug doses to avoid the possible confounding of litter with dose effects [9 (link),46 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!